Levetiracetam CAS 102767-28-2

Product Description:

Product Name: Levetiracetam CAS NO: 102767-28-2

Synonyms:

(S)-2-(2-Oxopyrrolidin-1-yl)Butanamide;

(2S)-2-(2-oxopyrrolidin-1-yl)butanamide;

(S)-2-(2-Oxo-1-pyrrolidinyl)butyramide;

Chemical & Physical Properties:

Appearance: White crystalline powder

Assay :≥99.00%

Density: 1.168 g/cm3

Boiling Point: 395.9℃ at 760 mmHg

Melting Point: 118-119℃

Flash Point: 193.2℃

Refractive Index: 1.518

Storage Condition: Store in original container in a cool dark place.

Vapor Pressure: 1.78E-06mmHg at 25℃

Safety Information:

RTECS: UX9656166

Safety Statement: S26-45-36/37-16-7

HS Code: 2933990090

Risk Statement: R22-36-39/23/24/25-23/24/25-11

Hazard Code: Xn

HS Code: 29337900

Levetiracetam, marketed under the trade name Keppra among others, is a medication used to treat epilepsy. It is used for partial onset, myoclonic, or tonic-clonic seizures. It is the S-enantiomer of etiracetam.

Levetiracetam is available by mouth in two forms: immediate release and extended release. An immediate release tablet has been available as a generic in the United States since November 2008, and in the UK since 2011. The United States patent for the extended release tablet expires September 17, 2028. It was initially patented by UCB Pharma.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.